Brief: Clinuvel Pharmaceuticals Renews Share Buy-Back Program
26/03/2025 22:04
March 27 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX: RENEWS SHARE BUY-BACK PROGRAM REPURCHASE OF UP TO 1.5 MILLION ORDINARY SHARES Source text: ID:nASXc2M58X Further company coverage: CUV.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist